Skip to menu Skip to content Skip to footer

2025

Journal Article

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)

Schleich, Florence, Larenas-Linnemann, Désirée, Altraja, Alan, Pérez de Llano, Luis, Kostikas, Konstantinos, Sadatsafavi, Mohsen, Bourdin, Arnaud, Alton Pleasants, Roy, Hew, Mark, Chen, Wenjia, Jiménez-Maldonado, Libardo, Couillard, Simon, Suppli Ulrik, Charlotte, Bulkhi, Adeeb A., Tsai, Ming-Ju, Christoff, George C., Papadopoulos, Nikolaos G., Pfeffer, Paul E., Ryan, Dermot, Bergeron, Celine, Al-Ahmad, Mona S., Dorscheid, Delbert R., Wang, Eileen, Blakey, John D., Cochrane, Belinda, Peters, Matthew J., Popov, Todor A., Torres-Duque, Carlos A., Hansen, Susanne ... Price, David B. (2025). Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR). World Allergy Organization Journal, 18 (7) 101066, 101066. doi: 10.1016/j.waojou.2025.101066

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)

2025

Journal Article

Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab

Hamada, Yuto, Thomas, Dennis, McDonald, Vanessa M., Harvey, Erin S., Fricker, Michael, Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Gibson, Peter G. (2025). Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Annals of Allergy, Asthma & Immunology. doi: 10.1016/j.anai.2025.06.017

Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab

2025

Journal Article

Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma

Hamada, Yuto, Gibson, Peter G., Harvey, Erin S., Stevens, Sean, Lewthwaite, Hayley, Fricker, Michael, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Thomas, Dennis (2025). Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. Journal of Allergy and Clinical Immunology: In Practice, 13 (2), 333-342.e9. doi: 10.1016/j.jaip.2024.10.041

Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma

2025

Journal Article

Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma

Jones, Arwel W., Mcdonald, Vanessa M., Mcloughlin, Rebecca F., Vella, Teresa M., Flynn, Anthony W., Blakey, John, Wolfenden, Luke, Hew, Mark, Upham, John W., Thomas, Dennis, Bardin, Philip and Holland, Anne E. (2025). Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma. Patient Preference and Adherence, 19, 75-85. doi: 10.2147/PPA.S487743

Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma

2025

Journal Article

Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics

Jurak, Lisa M., Yang, Ian A., Simpson, Jodie L., Gibson, Peter G., Hill, Michelle M. and Upham, John W. (2025). Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics. Journal of Allergy and Clinical Immunology, 155 (6), 1846-1856.e2. doi: 10.1016/j.jaci.2025.02.028

Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics

2025

Journal Article

Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma

Hamada, Yuto, Thomas, Dennis, Harvey, Erin S., Stevens, Sean, Fricker, Michael, Lewthwaite, Hayley, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Gibson, Peter G. (2025). Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. The European respiratory journal, 65 (1) 2400782, 2400782. doi: 10.1183/13993003.00782-2024

Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma

2025

Journal Article

Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion

Thomas, Dennis, Lewthwaite, Hayley, Gibson, Peter G., Majellano, Eleanor, Clark, Vanessa, Fricker, Michael, Hamada, Yuto, Anderson, Gary P., Backer, Vibeke, Bardin, Philip, Beasley, Richard, Chien, Jimmy, Farah, Claude S., Harrington, John, Harvey, Erin, Hew, Mark, Holland, Anne E., Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory, Murray, Kirsty, Peters, Matthew, Thomas, Rejoy, Tonga, Katrina, Upham, John W., Wark, Peter and McDonald, Vanessa M. (2025). Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion. Respirology, 30 (6), 466-479. doi: 10.1111/resp.70047

Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion

2024

Journal Article

Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma

Khaleva, Ekaterina, Brightling, Chris, Eiwegger, Thomas, Altraja, Alan, Bégin, Philippe, Blumchen, Katharina, Bossios, Apostolos, Bourdin, Arnaud, Ten Brinke, Anneke, Brusselle, Guy, Silvia Bumbacea, Roxana, Bush, Andrew, Casale, Thomas B, Clarke, Graham W., Chaudhuri, Rekha, Fan Chung, Kian, Coleman, Courtney, Corren, Jonathan, Dahlén, Sven-Erik, Deschildre, Antoine, Djukanovic, Ratko, Eger, Katrien, Exley, Andrew, Fleming, Louise, Fowler, Stephen J., Gaillard, Erol A., Gappa, Monika, Gupta, Atul, Michael Haitchi, Hans ... on behalf of the 3TR Asthma Definition of Response Working Group (2024). Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma. European Respiratory Journal, 65 (3) 2400691, 1-18. doi: 10.1183/13993003.00691-2024

Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma

2024

Journal Article

Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults

Perez-De-Llano, Luis, Scelo, Ghislaine, Tran, Trung N., Le, Tham T., Fagerås, Malin, Cosio, Borja G., Peters, Matthew, Pfeffer, Paul E., Al-Ahmad, Mona, Al-Lehebi, Riyad O., Altraja, Alan, Bergeron, Celine, Bjermer, Leif H., Bjerrum, Anne S., Bulathsinhala, Lakmini, Busby, John, Cano Rosales, Diana J., Canonica, Giorgio W., Carter, Victoria A., Charriot, Jeremy, Christoff, George C., Denton, Eve J., Dorscheid, Delbert R., Fernandez Sanchez, Maria J., Fonseca, João A., Gibson, Peter G., Goh, Celine Y.Y., Heaney, Liam G., Heffler, Enrico ... Price, David B. (2024). Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults. American Journal of Respiratory and Critical Care Medicine, 210 (7), 869-880. doi: 10.1164/rccm.202311-2192OC

Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults

2024

Journal Article

Exploring definitions and predictors of response to biologics for severe asthma

Scelo, Ghislaine, Tran, Trung N., Le, Tham T., Fagerås, Malin, Dorscheid, Delbert, Busby, John, Al-Ahmad, Mona, Al-Lehebi, Riyad, Altraja, Alan, Beastall, Aaron, Bergeron, Celine, Bjermer, Leif, Bjerrum, Anne S., Cano-Rosales, Diana Jimena, Canonica, Giorgio Walter, Carter, Victoria, Charriot, Jeremy, Christoff, George C., Cosio, Borja G., Denton, Eve, Fernandez-Sanchez, Maria Jose, Fonseca, João A., Gibson, Peter G., Goh, Celine, Heaney, Liam G., Heffler, Enrico, Hew, Mark, Iwanaga, Takashi, Katial, Rohit ... Price, David B. (2024). Exploring definitions and predictors of response to biologics for severe asthma. Journal of Allergy and Clinical Immunology: In Practice, 12 (9), 2347-2361. doi: 10.1016/j.jaip.2024.05.016

Exploring definitions and predictors of response to biologics for severe asthma

2024

Journal Article

Real-world biologics response and super-response in the International Severe Asthma Registry cohort

Denton, Eve, Hew, Mark, Peters, Matthew J., Upham, John W., Bulathsinhala, Lakmini, Tran, Trung N., Martin, Neil, Bergeron, Celine, Al-Ahmad, Mona, Altraja, Alan, Larenas-Linnemann, Desiree, Murray, Ruth, Celis-Preciado, Carlos Andres, Al-Lehebi, Riyad, Belhassen, Manon, Bhutani, Mohit, Bosnic-Anticevich, Sinthia Z., Bourdin, Arnaud, Brusselle, Guy G., Busby, John, Canonica, Giorgio Walter, Heffler, Enrico, Chapman, Kenneth R., Charriot, Jeremy, Christoff, George C., Chung, Li Ping, Cosio, Borja G., Cote, Andreanne, Costello, Richard W. ... Price, David B. (2024). Real-world biologics response and super-response in the International Severe Asthma Registry cohort. Allergy, 79 (10), 2700-2716. doi: 10.1111/all.16178

Real-world biologics response and super-response in the International Severe Asthma Registry cohort

2024

Journal Article

Twenty-four month outcomes of extended- versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trial

Kok, Hing C., McCallum, Gabrielle B., Yerkovich, Stephanie T., Grimwood, Keith, Fong, Siew M., Nathan, Anna M., Byrnes, Catherine A., Ware, Robert S., Nachiappan, Nachal, Saari, Noorazlina, Morris, Peter S., Yeo, Tsin W., Oguoma, Victor M., Masters, I. Brent, de Bruyne, Jessie A., Eg, Kah P., Lee, Bilawara, Ooi, Mong H., Upham, John W., Torzillo, Paul J. and Chang, Anne B. (2024). Twenty-four month outcomes of extended- versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trial. Pediatric Infectious Disease Journal, 43 (9), 872-879. doi: 10.1097/inf.0000000000004407

Twenty-four month outcomes of extended- versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trial

2024

Journal Article

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Thomas, Dennis, McDonald, Vanessa M., Stevens, Sean, Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A. and Gibson, Peter G. (2024). Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy, 79 (2), 384-392. doi: 10.1111/all.15867

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

2024

Journal Article

Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial

Thomas, Dennis, McDonald, Vanessa M., Stevens, Sean, Baraket, Melissa, Hodge, Sandra, James, Alan, Jenkins, Christine, Marks, Guy B., Peters, Matthew, Reynolds, Paul, Upham, John W., Yang, Ian A. and Gibson, Peter G. (2024). Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial. CHEST, 166 (2), 262-270. doi: 10.1016/j.chest.2024.02.048

Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial

2024

Journal Article

Effects of moderate- versus vigorous-intensity exercise training on asthma outcomes in adults

Valkenborghs, Sarah R., Wood, Lisa G., Callister, Robin, Upham, John W., Grainge, Christopher L., Anderson, Sophie, Williams, Lily M., McLoughlin, Rebecca F., Williams, Evan J. and Scott, Hayley A. (2024). Effects of moderate- versus vigorous-intensity exercise training on asthma outcomes in adults. Journal of Allergy and Clinical Immunology: In Practice, 12 (10), 2744-2753. doi: 10.1016/j.jaip.2024.06.015

Effects of moderate- versus vigorous-intensity exercise training on asthma outcomes in adults

2023

Journal Article

Impact of landscape fire smoke exposure on patients with asthma with or without laryngeal hypersensitivity

Vertigan, Anne E., Harvey, Erin S., Beyene, Tesfalidet, Van Buskirk, Joseph, Holliday, Elizabeth G., Bone, Sarah L., McDonald, Vanessa M., Horvat, Jay C., Murphy, Vanessa E., Jensen, Megan E., Morgan, Geoffrey G., Zosky, Graeme R., Peters, Matthew, Farah, Claude S., Jenkins, Christine R., Katelaris, Constance H., Harrington, John, Langton, David, Bardin, Philip, Katsoulotos, Gregory P., Upham, John W., Chien, Jimmy, Bowden, Jeffrey J., Rimmer, Janet, Bell, Rose and Gibson, Peter G. (2023). Impact of landscape fire smoke exposure on patients with asthma with or without laryngeal hypersensitivity. The Journal of Allergy and Clinical Immunology: In Practice, 11 (10), 3107-3115.e2. doi: 10.1016/j.jaip.2023.06.015

Impact of landscape fire smoke exposure on patients with asthma with or without laryngeal hypersensitivity

2023

Journal Article

Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics

Malik, Bilal, Bartlett, Nathan W., Upham, John W., Nichol, Kristy S., Harrington, John and Wark, Peter A. B. (2023). Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics. Respirology, 28 (8), 758-766. doi: 10.1111/resp.14506

Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics

2023

Journal Article

Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study

Samaranayake, Chinthaka Bhagya, Upham, John, Tran, Khoa, Howard, Luke S, Nguyen, Sean, Lwin, Myo, Anderson, James, Wahi, Sudhir, Price, Laura C, Wort, Stephen, Li, Wei, McCabe, Colm and Keir, Gregory J (2023). Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. BMJ Open Respiratory Research, 10 (1) e001637, e001637. doi: 10.1136/bmjresp-2023-001637

Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study

2023

Journal Article

Can Allergen Immunotherapy Improve Antiviral Immunity in Patients with Allergic Asthma?

Upham, John W. (2023). Can Allergen Immunotherapy Improve Antiviral Immunity in Patients with Allergic Asthma?. American Journal of Respiratory and Critical Care Medicine, 207 (9), 1112-1114. doi: 10.1164/rccm.202302-0234ed

Can Allergen Immunotherapy Improve Antiviral Immunity in Patients with Allergic Asthma?

2023

Journal Article

Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma

Kritikos, Vicky, Harvey, Erin S., Stevens, Sean, Katelaris, Constance H., Langton, David, Rimmer, Janet, Farah, Claude S., Gillman, Andrew, Hew, Mark, Radhakrishna, Naghmeh, Thomas, Dennis, Gibson, Peter G., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Grainge, Christopher, Harkness, Nicholas, Harrington, Zinta, Jenkins, Christine, Katsoulotos, Gregory P., McDonald, Vanessa M., Lee, Joy, Peters, Matthew, Reddel, Helen K., Reynolds, Paul N., Sivakumaran, Pathmanathan ... Wark, Peter A. B. (2023). Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma. Journal of Allergy and Clinical Immunology: In Practice, 11 (3), 885-895.e13. doi: 10.1016/j.jaip.2022.12.004

Comorbidities modify the phenotype but not the treatment effectiveness to mepolizumab in severe eosinophilic asthma